These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38061972)

  • 1. Inflammatory mesenteric fat detected by Intestinal ultrasound is correlated with poor long-term clinical outcomes in patients with Crohn's disease.
    Cheng W; Huang Z; Qin S; Liang Z; Gao X; Liu G; Guo Q
    Dig Liver Dis; 2024 May; 56(5):723-729. PubMed ID: 38061972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline and Postinduction Intestinal Ultrasound Findings Predict Long-term Transmural and Mucosal Healing in Patients With Crohn's Disease.
    Huang Z; Cheng W; Chao K; Tang J; Li M; Guo Q; Liu G; Gao X
    Inflamm Bowel Dis; 2024 Oct; 30(10):1767-1775. PubMed ID: 37889843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.
    Colombel JF; Reinisch W; Mantzaris GJ; Kornbluth A; Rutgeerts P; Tang KL; Oortwijn A; Bevelander GS; Cornillie FJ; Sandborn WJ
    Aliment Pharmacol Ther; 2015 Apr; 41(8):734-46. PubMed ID: 25728587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn's disease.
    Alfaro I; Masamunt MC; Planell N; López-García A; Castro J; Gallego M; Barastegui R; Giner A; Vara A; Salas A; Ricart E; Panés J; Ordás I
    World J Gastroenterol; 2019 Apr; 25(14):1764-1774. PubMed ID: 31011260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission.
    Lin X; Qiu Y; Feng R; Chen B; He Y; Zeng Z; Zhang S; Chen M; Mao R
    Clin Transl Gastroenterol; 2020 Feb; 11(2):e00135. PubMed ID: 32463625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Impact of Sonographic Transmural Healing After Anti-TNF Antibody Treatment in Patients with Crohn's Disease.
    Paredes JM; Moreno N; Latorre P; Ripollés T; Martinez MJ; Vizuete J; Moreno-Osset E
    Dig Dis Sci; 2019 Sep; 64(9):2600-2606. PubMed ID: 30874986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn's disease.
    Beppu T; Ono Y; Matsui T; Hirai F; Yano Y; Takatsu N; Ninomiya K; Tsurumi K; Sato Y; Takahashi H; Ookado Y; Koga A; Kinjo K; Nagahama T; Hisabe T; Takaki Y; Yao K
    Dig Endosc; 2015 Jan; 27(1):73-81. PubMed ID: 24833527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral Fat Is Associated With Mucosal Healing of Infliximab Treatment in Crohn's Disease.
    Shen W; Cao L; Li Y; Cai X; Ge Y; Zhu W
    Dis Colon Rectum; 2018 Jun; 61(6):706-712. PubMed ID: 29722729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Infliximab Levels With Mucosal Healing Is Time-Dependent in Crohn's Disease: Higher Drug Exposure Is Required Postinduction Than During Maintenance Treatment.
    Feng T; Chen B; Ungar B; Qiu Y; Zhang S; He J; Lin S; He Y; Zeng Z; Ben-Horin S; Chen M; Mao R
    Inflamm Bowel Dis; 2019 Oct; 25(11):1813-1821. PubMed ID: 30934050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transmural healing and mucosal healing as predictors of positive long-term outcomes in Crohn's disease.
    Ma L; Li W; Zhuang N; Yang H; Liu W; Zhou W; Jiang Y; Li J; Zhu Q; Qian J
    Therap Adv Gastroenterol; 2021; 14():17562848211016259. PubMed ID: 34178114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Looking Beyond Mucosal Healing: Effect of Biologic Therapy on Transmural Healing in Pediatric Crohn's Disease.
    Civitelli F; Nuti F; Oliva S; Messina L; La Torre G; Viola F; Cucchiara S; Aloi M
    Inflamm Bowel Dis; 2016 Oct; 22(10):2418-24. PubMed ID: 27598739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
    Danese S; Sandborn WJ; Colombel JF; Vermeire S; Glover SC; Rimola J; Siegelman J; Jones S; Bornstein JD; Feagan BG
    Gastroenterology; 2019 Oct; 157(4):1007-1018.e7. PubMed ID: 31279871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease.
    Grover Z; Burgess C; Muir R; Reilly C; Lewindon PJ
    J Crohns Colitis; 2016 Oct; 10(10):1159-64. PubMed ID: 26980840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents.
    Castiglione F; Mainenti P; Testa A; Imperatore N; De Palma GD; Maurea S; Rea M; Nardone OM; Sanges M; Caporaso N; Rispo A
    Dig Liver Dis; 2017 May; 49(5):484-489. PubMed ID: 28292640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical remission and transmural healing of ustekinumab in patients with Crohn's disease].
    Wu Y; Xu Y; Zhang G; Zhang Y; Wang J; You P; Peng T; Liu Y; Chen N
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):253-259. PubMed ID: 38595241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab Trough Levels Are Associated With Transmural Sonographic Healing in Inflammatory Bowel Disease.
    Vaughan R; Murphy E; Nalder M; Gibson RN; Ardalan Z; Boussioutas A; Christensen B
    Inflamm Bowel Dis; 2023 Jul; 29(7):1080-1088. PubMed ID: 36094156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab.
    Bertani L; Fornai M; Fornili M; Antonioli L; Benvenuti L; Tapete G; Baiano Svizzero G; Ceccarelli L; Mumolo MG; Baglietto L; de Bortoli N; Bellini M; Marchi S; Costa F; Blandizzi C
    Aliment Pharmacol Ther; 2020 Jul; 52(2):284-291. PubMed ID: 32506635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn's Disease.
    Wong ECL; Buffone E; Lee SJ; Dulai PS; Marshall JK; Reinisch W; Narula N
    J Crohns Colitis; 2021 Jul; 15(7):1114-1119. PubMed ID: 33245751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.